PharmaCann Penn Plant — a part of PharmaCann, a medical cannabis business with dispensaries and cultivation facilities in Illinois and New York — recently purchased 18 acres from the Scranton Lackawanna Industrial Building Company.
The land is in the Scott Technology Park. PharmaCann will build a $10 million to $15 million, 36,000 square-foot, state-of-the-art pharmaceutical-grade medical marijuana growing and processing facility. It will be Scranton’s second such facility.
The facility will employ up to 40 people, with a minimum wage of $15 an hour, and is expected to be fully operational next July.
PharmaCann Penn Plant received its license in July from the Pennsylvania Medical Marijuana program. The state has issued 25 licenses.
“The long-standing focus of the Scott Technology Park has been to nurture businesses at the cutting edge of their respective fields,” Bob Durkin, president of The Greater Scranton Chamber of Commerce, said. “PharmaCann is doing just that by employing a team of highly skilled professionals both attracted to and drawn from our local talent pool.”
The Scott Technology Park already houses five buildings, totaling 201,520 square feet and employing 787 people.
PharmaCann was acquired by MedMen Enterprises earlier this year. MedMen is a publicly traded cannabis company with 19 cannabis facilities nationwide.